In a landmark development in the treatment of relapsed small cell lung cancer (SCLC), scientists have unveiled promising results from...

In a groundbreaking advancement for small cell lung cancer (SCLC) therapy, recent data unveiled at the International Association for the...

In a groundbreaking advancement for the treatment of ROS1-positive non-small cell lung cancer (NSCLC), a novel investigational agent, zidesamtinib, has...

In a significant development in the field of thoracic oncology, recent findings from the Phase 3 E4512 clinical trial have...

In a groundbreaking advancement for the management of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR)...

In a groundbreaking advancement within the realm of targeted oncology, the international cancer research community has witnessed compelling evidence supporting...

In a pivotal advancement for the treatment of advanced non-small cell lung cancer (NSCLC), new data from the ACROSS 2...

Recent studies in the field of oncology have shed light on the complexities of glioblastoma, a highly aggressive brain tumor...

In a groundbreaking development presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on...

In a groundbreaking advancement for the treatment of non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations,...